Discontinued — last reported Q4 '22
Moderna Collaboration revenue — Total Revenue increased by 190.0% to $290.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric grew by 1971.4%, from $14.00M to $290.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase reflects successful achievement of research milestones or strong demand for the company's platform technology by partners.
This is the total revenue recognized from collaboration arrangements during the reporting period, derived from milestone...
Standard metric across the biotech industry; peers report this as 'Collaboration Revenue' or 'License and Collaboration Revenue'.
mrna_segment_collaboration_revenue_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $18.00M | $19.00M | $14.00M | $15.00M | $35.00M | $100.00M | $290.00M |
| QoQ Change | — | +5.6% | -26.3% | +7.1% | +133.3% | +185.7% | +190.0% |
| YoY Change | — | — | — | — | +94.4% | +426.3% | >999% |